DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG

DEWB Investment Holding LemnaTec Secures Equity Financing from Anterra Capital - Seite 2

Announcement of this financing follows several notable achievements by LemnaTec in recent months including opening an office in St. Louis, USA and starting construction of a high output field based phenotyping facility in the UK with Rothamsted Research.

About LemnaTec GmbH LemnaTec was founded in 1998 and since then the company has developed a range of research platforms and analysis software for agricultural chemistry, plant cultivation, biotechnology and pharmaceutical research. LemnaTec employs a multi-disciplinary team of biologists, physicians, chemists, bioinformaticians and ecotoxicologists, as well as hardware and software engineers, and together this team services a large estate of internationally renowned companies and institutes. For further information please visit http://www.lemnatec.com

About Anterra Capital Anterra Capital, a growth capital fund, is jointly funded by Moonray Investors, the proprietary investment arm of FIL Limited, the parent company of Fidelity Worldwide Investment, and Rabo Private Equity, the proprietary private equity arm of Rabobank. Anterra Capital invests in fast growing companies that are working to make the global food supply chain safer, more efficient and more sustainable. For further information please visit http://www.anterracapital.com

About DEWB Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG (DEWB AG, Entry Standard, WKN: 804100 / ISIN: DE0008041005) is an investment company specialising on young and established medium-sized companies. Their investment activities are focused on high-growth companies with the technology focus on photonics and sensor technology, as well as their fields of application in production and automation engineering and adjacent areas. They support these companies with equity capital, corporate development expertise, and a broad industry network. Since 1997, they have invested more than 360 million Euro in 59 companies and generated more than 465 million Euro in returns from 43 exits, including eight initial public offerings. The company is headquartered in Jena, Germany, one of the country's most successful regions for technology and science, with a long-standing tradition in the field of optical technologies and one of the most important European centers for photonics. For further information please visit http://www.dewb.de



(end)

emitter: DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG address: Fraunhoferstraße 1, 07743 Jena country: Germany contact person: Marco Scheidler phone: [phone] e-mail: [e-mail] website: www.dewb.de

ISIN(s): DE0008041005 (share) stock exchanges: entry standard in Frankfurt, free market in Stuttgart, free market in Munich; open market in Berlin

[ source: http://www.pressetext.com/news/20150303018 ]